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Tyrosinase-related protein-1 (TRP-1) is a 75 kDa
type-1 transmembrane glycoprotein localized to the
melanosome. The mechanism by which newly
synthesized TRP-1 reaches its ultimate destination is
currently unknown, but has been speculated to occur
via the endosomal pathway. Recently, it has been
shown that phosphatidylinositide (PI) 3-kinase is
involved in various cellular functions, including regu-
lating the constitutive movement of proteins from
one intracellular compartment to another; however,
whether PI 3-kinase participates in the traf®cking of
proteins such as TRP-1 to the melanosome is
unknown. In this study we investigate the role of PI
3-kinase on the traf®cking of TRP-1 in human mela-
noma MeWo cells using wortmannin, a potent inhibi-
tor of PI 3-kinase. Our investigations demonstrate
that wortmannin interferes with the membrane
traf®cking of TRP-1 in MeWo cells, and that it
speci®cally results in the redistribution of the protein
within a novel vesicular compartment with character-
istics of the endosomal and lysosomal compartments
[positive for LAMP-1, and partially positive for CD63
and cation-independent mannose 6-phosphate recep-
tors (CI-M6PR)], and is accessible to internalized
proteins such as immunoglobulins. Movement within
this novel compartment is microtubule and GTPase
dependent. These ®ndings have led us to postulate
that TRP-1 is sorted from the trans-Golgi network to
a compartment in the vicinity of late endosomes,
traf®cking from which to the melanosome appears to
be dependent on PI 3-kinase as it is blocked by wort-
mannin. Key words: lysosomes/melanogenesis/melanosome
biogenesis/wortmannin. Journal of Investigative
Dermatology Symposium Proceedings 6:105±114, 2001
T
he intracellular pathways of transport and sorting of
newly synthesized proteins to lysosomes in non-
melanocytic cells has been extensively studied and is
well characterized. Our understanding of the pathways
of transport of proteins to the melanosome (site of
melanin pigment synthesis) in melanocytic cells is less well known.
Based on biochemical and immunocytochemical studies, lyso-
somes are thought to originate from a vesicular prelysosomal
compartment (PLC) known as late endosomes (Kornfeld and
Mellman, 1989; Heller et al, 1994). In contrast, the origin of
melanosomes has yet to be established but is presumed to arise from
a compartment between the endosomes and lysosomes based on
biochemical similarities in organellogenesis (Diment et al, 1995).
These similarities include low pH, the presence of a proton-
transporting ATPase (Bhatnagar et al, 1993), acid phosphatase
(Novak and Swank, 1979), various lysosomal hydrolases (Diment
et al, 1995), and lysosomal membrane proteins (LAMP-1 and
CD63) (Metzelaar et al, 1991; Zhou et al, 1993). It has been
postulated that melanosomes arise via a bi-partite process (Jimbow
et al, 1971, 1993; Orlow, 1995). Initially, premelanosomal com-
partment containing matrix proteins bud from the smooth ER and
then undergo maturation to form stage II melanosomes. The latter
fuse with tyrosinase-containing coated vesicles derived from the
trans-Golgi network (TGN), which initiates the process of
melanogenesis.
Genetic and biochemical studies have identi®ed several proteins
that in¯uence melanin synthesis and the structural integrity of the
melanosomal compartment. These melanogenic proteins, known as
tyrosinase and its related proteins (TRP), are localized primarily to
the melanosomal membrane (Marmol and Beermann, 1996). The
best characterized is TRP-1 (gp 75), the human homolog of the
mouse b (brown) locus gene product (Vijayasaradhi et al, 1990). It is
the most abundant of membrane-bound glycoproteins in melano-
cytes, and is expressed in early unmelanized melanosomes, i.e.,
Stage I and II melanosomes (Thomson et al, 1988; Vijayasaradhi
et al, 1991; Der et al, 1993; Orlow et al, 1993). Initial distribution
studies revealed little or no TRP-1 expression on the cell surface of
melanocytic cells (Vijayasaradhi et al, 1991). More recent investig-
ations have, however, suggested that TRP-1 may be expressed on
the plasma membrane (Jimbow et al, 1993) and even secreted under
certain conditions (Giacomini et al, 1992; Xu et al, 1997). TRP-1 is
synthesized as a 55 kDa polypeptide in the rough ER where it is
glycosylated with ASN-linked oligosaccharides forming a major
69 kDa and minor 67 kDa glycoprotein (Vijayasaradhi et al, 1991;
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Hearing et al, 1998). In the Golgi apparatus it undergoes full
maturation, and is sorted from the TGN to the melanosomes as a
broad 72±75 kDa glycoprotein, presumably via transport vesicles
(Der et al, 1993).
The biochemical machinery governing the transport of TRP-1
from the Golgi to its ultimate destination, the melanosome, is not
well understood. The similarities between melanosomes and
lysosomes would suggest a common endosomal pathway of
biogenesis (Vijayasaradhi et al, 1995; Xu et al, 1997; Jimbow et al,
2000a,b). Furthermore, little is known about the route that the
newly synthesized melanosomal protein takes to reach the
melanosomal compartment. As previously noted (Orlow, 1995;
Jimbow et al, 2000a), delivery of TRP-1 to melanosomes is
thought to arise from the fusion of transport coated vesicles with
preexisting melanosomes (Stage II). In addition, it has been
proposed that a distinct premelanosomal compartment exists, and is
separable from conventional endosomes and lysosomes, as it
contains Pmel17, a structural melanosomal protein (Raposo et al,
1996, 2001).
Phosphatidylinositide 3-kinase is involved in the regulation of
membrane traf®cking events. The yeast protein, VPS34p, shares
sequence homology with p110, a catalytic subunit of a mammalian
phosphatidylinositide (PI) 3-kinase (Herman and Emr, 1990; Hiles
et al, 1992), and exhibits PI 3-kinase activity (Schu et al, 1993).
Studies on VPS34p yeast protein have demonstrated that PI3-
kinase is essential for vacuolar protein sorting and vacuolar
morphogenesis. Mutations or deletions in VPS34p alter the sorting
of newly synthesized proteins to the yeast vacuole (Herman et al,
1992; Stack and Emr, 1994). In mammalian cells, PI 3-kinase has
been shown to be involved with various membrane traf®cking
processes that occur within the endocytic pathway, such as in
insulin-regulated glucose transporter recycling, downregulation of
platelet-derived growth factor (PDGF) receptor, completion of
macropinocytosis and phagocytosis by macrophages, and the
sorting and transport of lysosomal enzymes (Brown et al, 1995;
Joly et al, 1995; Reaves et al, 1996). The availability of two cell-
permeable inhibitors of PI 3-kinase, LY294002 (Vlahos et al, 1994)
and wortmannin (WTM) (Arcaro and Wymann, 1994), have
contributed greatly to our understanding of PI 3-kinase in
membrane traf®cking events. WTM is a fungal metabolite that
selectively and irreversibly inhibits PI 3-kinase activity at
nanomolar concentrations both in vitro and in vivo by covalently
binding to the catalytic p110 subunit of the enzyme (Arcaro and
Wymann, 1994; Powis et al, 1994). Although the mechanism and
site of action of PI 3-kinase in membrane traf®c has yet to be
determined, a growing body of evidence suggests that PI 3-kinase
affects movement at the TGN-endosomal-PLC system (Shpetner
et al, 1996).
Previous studies on WTM have prompted us to examine the
effects of this inhibitor on the membrane traf®cking of TRP-1 in
melanocytic cells. TRP-1 is of particular interest because it is
known to in¯uence the structure of melanosomes, and to regulate
the type of melanin produced (Vijayasaradhi et al, 1991). In this
study we found that treatment of MeWo melanoma cells with
WTM resulted in the appearance of a peripheral tubulo-vesicular
network, and a novel, centrally located, swollen vacuolar com-
partment with characteristics of late endosomes/lysosomes.
Although the morphology and distribution of melanosomes was
markedly affected by WTM, the rate and extent of biogenesis of
TRP-1 was not perturbed, suggesting that WTM does not divert
the normal traf®cking of the protein. Our ®ndings indicate that PI
3-kinase plays a critical role in the sorting of TRP-1 into the
melanosomal pathway, presumably at a prelysosomal/late endo-
somal compartment.
MATERIALS AND METHODS
Materials and cells Brefeldin A (BFA) (Epicentre Technologies,
Madison, WI) was dissolved in methanol as a 10 mg per ml stock
solution and was stored at ±20°C. WTM (Sigma, St. Louis, MO) and
LY294002 (Calbiochem-Novabiochem International, La Jolla, CA) were
dissolved in DMSO to ®nal concentrations of 10 mM and 20 mM,
respectively, dispensed as 5 ml aliquots and stored at ±20°C. Because
WTM is unstable in aqueous solutions and is photosensitive, it was
routinely thawed, diluted, and added to cells within 10 min; unused
thawed aliquots of WTM were discarded. Nocodazole was stored as a 10
mg per ml stock solution in DMSO. All other chemicals unless
otherwise indicated were obtained from Sigma.
Human melanoma MeWo cells were a gift of Dr. R. Kerbel at Mount
Sinai Hospital Research Institute (Toronto, Ontario, Canada). It is a
partially melanotic, TRP-1-positive melanoma cell line that shares many
characteristics with the well-characterized human melanoma cell line Mel
Juso (Tulp et al, 1994). Cells were grown in RPMI 1640 medium with
10% fetal calf serum (Biowittaker, Walkersville, MD) and 100 units per
ml penicillin and 100 mg per ml streptomycin (Gibco BRL, Burlington,
Ontario) at 37°C in a humidi®ed atmosphere of 95% air and 5% CO2.
Mouse monoclonal antibodies (MoAb) to TRP-1 (clone HMSA-5)
and CD63 (clone HMSA-7) were raised against puri®ed melanosomes as
previously described (Der et al, 1993; Jimbow et al, 1993). Mouse
monoclonal antihuman LAMP-1 antibody (clone 1D4B) was obtained
from the Developmental Studies Hybridoma Bank, John Hopkins
University (Baltimore, MD). Other antibodies and their source are as
follows: (i) rabbit polyclonal antihuman LAMP-1 (Carlsson et al, 1988)
(Dr. M. Fukuda, La Jolla Cancer Research Foundation, La Jolla, CA);
(ii) rabbit polyclonal antication-independent mannose-6 phosphate recep-
tor (CI-M6PR) (Dr. S. Kornfeld, Washington University, St. Louis,
MO); and (iii) rabbit polyclonal anti-TRP-1 (a-PEP-1) (Dr. V. Hearing,
National Institutes of Health, Bethesda, MD). All ¯uorescein isothio-
cyanate (FITC) or rhodamine conjugated antibodies were obtained from
Boehringer Mannheim (Laval, Quebec) unless otherwise indicated.
Rabbit polyclonal antibody to the PI 3-kinase p110 subunit was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Radioactive [a-32P] ATP and [35S] methionine were purchased from
Amersham Life Science (Oakville, Ontario).
Cell labelling and immunoprecipitation MeWo cells were grown
to 75% con¯uence on 75 cm2 tissue culture ¯asks and then starved with
methionine-free RPMI 1640 medium (Gibco-BRL) for 1 h. Cells were
then incubated with 300 mCi of [35S] methionine from 5 to 10 min to
4 h. Cells were washed once with PBS and chased using methionine-
containing RPMI 1640 media for varying times in the presence or
absence of BFA or WTM. Cells were lyzed directly on the ¯asks by
adding 500 ml of RIPA buffer (150 mM NaCl, 50 mM Tris, pH 8.0,
0.1% SDS, 0.5% deoxycholic acid, and 1% NP-40), and containing a
cocktail of protease inhibitors including pepstain (10 mg per ml),
leupeptin (10 mg per ml), and 0.25% aprotinin for 30 min on ice
(Boehringer Mannheim). The lysates were centrifuged at 12 000 3 g for
15 min at 4°C. The postnuclear supernatants were precleared with
mouse and/or rabbit serum agarose and protein A-sepharose (Pharmacia,
Montreal, Quebec) for 1 h, and aliquots of lysates were incubated with
an appropriate amount of antibodies for 1±2 h followed by a bridging
antibody goat antimouse IgG (Cappel, Organon Teknika, Toronto,
Ontario), and protein A-sepharose for 1 h. The immuno-beads were
washed twice with washing buffer (250 mM NaCl, 5 mM EDTA,
50 mM Tris, pH 7.5 containing 1% NP-40), and once with the washing
buffer without NP-40. The immuno-complexes were eluted from the
beads by the addition of sample buffer, analyzed by SDS-PAGE, and
visualized by ¯uorography and autoradiography.
Immuno¯uorescent microscopy For all of the immuno¯uorescent
microscopy experiments described below, cells were grown for 2 d (until
about 75% con¯uence) on 8-chamber glass slides (Gibco-BRL)
(pretreated with 0.01% Poly L-lysine) in RPMI 1640 media containing
10% fetal bovine serum. Cells were treated with various concentrations
of WTM or other pharmacologic agents as indicated in the Results. After
the appropriate drug treatments, cells were washed twice by quickly
dunking the chamber slide in a beaker containing approximately 200 ml
PBS, ®xed, and permeabilized by incubating in ice-cold methanol/
acetone (1:1) for 5±10 min. Cells were further processed for single or
double-labeling immuno¯uorescent by incubating with primary anti-
bodies in 1%BSA for 1 h at room temperature. Excess antibodies were
removed by washing in PBS, and the cells were then incubated further
at room temperature with ¯uorescein-labeled secondary antibody for 1 h,
washed in PBS, then water, air dried, and mounted in Fluoro-mount
(BDH Laboratory Supplies, Poole, UK). Slides were photographed using
a Carl Zeiss ¯uorescent microscope and ®lmed with Kodak Ektachrome
(P1600 or T-MAX 1600). Internalized anti-TRP-1 antibodies in the
antibody uptake experiments were detected using rhodamine-conjugated
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goat antimouse IgG. The intracellular distribution of TRP-1 or CD63
antigens was detected with rabbit anti-TRP-1 or anti-CD63 antibodies
followed by ¯uorescein-conjugated swine antirabbit IgG (DAKO
Diagnostics, Toronto, Ontario).
PI 3-kinase assay PI 3-kinase activity was assessed as described by
Whitman et al (1985). Brie¯y, PI 3-kinase was isolated from MeWo cells
cultured on 175 cm2 culture plates by immunoprecipitation with
antibody to its catalytic p110 subunit. The immunoprecipitates (20 ml
pellet of protein-A sepharose beads) were extensively washed, then
exposed to varying concentrations of wortmannin (0.01±10 mM) in
100 ml of 20 mM Tris-HCl buffer (pH 7.5) containing 100 mM NaCl,
5 mM MgCl2, 0.5 mM EGTA, 0.5 mM p-nitrophenylphosphate,
0.2 mM adenosine, 0.5 mg per ml L-a-phosphatidylinositol, and L-a-
phosphatidylserine (Avanti Polar Lipids, Alabaster, AL), at 37°C.
Phosphorylation was initiated by exposure to [a-32P] ATP (50 mM,
50 mCi) for 15 min at room temperature. The reaction was terminated
with 50 ml of 1 N HCl. The lipid products were extracted with CHCl3/
CH3OH, 1:1 (vol/vol). The solvent-extracted phospholipids were
applied to silica gel plates (Kieselgel 60 W, E.Merk, Germany) and
developed in chloroform:methanol:acetone:glacial acetic acid:water
solution (40:13:15:12:7). Radioactive lipids were quanti®ed using
PhosphoImager (Molecular Dynamics, Sunnyvale, CA).
RESULTS
WTM results in the formation of a tubulo-vesicular network
and macrovesicles To investigate the role of PI 3-kinase in the
transport and targeting of newly synthesized TRP-1 molecules,
MeWo melanoma cells were cultured on 8-chamber glass slides and
exposed to various concentrations of WTM for 1 h (0.01±5 mM).
Glass slides were ®xed in cold methanol/acetone and assessed by
indirect immuno¯uorescent microscopy for their pattern of staining
for TRP-1. In untreated cells, TRP-1 labeled melanosomes were
clustered as distinct vesicles in a juxtanuclear region and throughout
the cytoplasm as previously reported (Fig 1a) (Vijayasaradhi et al,
1995). Treatment with WTM for 1 h (at 0.01 mM) resulted in a
shift in their distribution and appearance. Speci®cally, the newly
synthesized TRP-1 vesicles appeared enlarged and fused forming a
tubulo-reticular network, and were more centrally located within
the cytoplasm (Fig 1b). With increasing concentrations of WTM,
the effects became more pronounced. Rather than being randomly
scattered throughout the cytoplasm, enlarged TRP-1-positive
vesicles were primarily distributed at the periphery and organized
into tubular networks (Fig 1c). At 1 mM concentration of WTM,
massively enlarged vesicles (``macrovesicles'') were seen located in a
juxtanuclear position (Fig 1d). With further increases in the
concentration of WTM, there was a reciprocal relationship
between the degree of tubulation and the presence of
macrovesicles. We found that at 5 mM of WTM, the number of
macrovesicles was maximal, whereas the extent of tubulation was
considerably less prominent (Fig 1e).
To con®rm that the morphologic changes of the newly
synthesized TRP-1 vesicles in MeWo cells by WTM treatment
was due to inhibition of PI 3-kinase, identical experiments were
performed using LY294002. LY294002 is a bio¯avinoid quercetin
analog that selectively inhibits PI 3-kinase activity (Vlahos et al,
1994). Similar morphologic observations in TRP-1 positive
vesicles were seen with LY294002 treatment of MeWo cells, albeit
at a concentration 100-fold greater than that of WTM (data not
shown). These results suggest that the transport of newly
synthesized TRP-1 vesicles is dependent on PI 3-kinase activity.
WTM inhibits PI 3-kinase In addition to inhibiting PI 3-
kinase, WTM blocks a number of enzymatic processes, e.g., PI 4-
kinase, phospholipase A2, and DNA protein kinase. To con®rm
that the effects of WTM on MeWo cell TRP-1 vesicles were due
to inhibition of PI 3-kinase rather than due to interference with
other cellular events, PI 3-kinase enzyme activity and the
production of phosphotidylinositol 3-P (PI(3)P) were measured.
PI 3-kinase was isolated from MeWo cell lysates by immuno-
precipitation using antibody to its catalytic p110 subunit. The
washed immuno-complexes were exposed to various concentra-
tions of WTM (0.001±10 mM), and the production of PI(3)P was
monitored by thin-layer chromatography (TLC) identi®ed by its
Figure 1. WTM induces newly synthesized
TRP-1 enriched vesicles to form a tubular
network and results in the appearance of
swollen vesicles (macrovesicles) in a
concentration-dependent manner. MeWo
cells were treated with WTM at various
concentrations for 1 h at 37°C: (a) untreated
controls, (b) 0.01 mM, (c) 0.1 mM, (d) 1 mM, and
(e) 5 mM. Slides were ®xed with methanol/
acetone and incubated with antibody to TRP-1
and followed by ¯uorescein-labeled goat
antimouse IgG. Arrows indicate WTM-induced
tubular structures, whereas arrowheads point to
macrovesicles.
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comigration with a standard PI(3)P synthesized by PI 3-kinase.
Enzyme activity was expressed as a percentage of that seen in
untreated controls.
At a WTM concentration of 0.1 mM, the activity of PI 3-kinase
was reduced by about 80%, and was almost completely abolished
at a WTM concentration of 10 mM (Fig 2a). With inhibition of
PI 3-kinase activity there was a marked reduction in the formation
of PI(3)P (Fig 2b). At a WTM concentration of 10 mM,
PI(3)P formation was nondetectable. The results indicate that
WTM is capable of inhibiting the production of PI(3)P in
MeWo cells.
Movement of newly synthesized TRP-1 molecules in the
post-Golgi region The presence of swollen vacuoles after
WTM treatment has been previously reported and is postulated
to arise from perturbation of membrane ¯ow from the late
endosome/prelysosomal compartments (Brown et al, 1995; Reaves
et al, 1996). Con¯icting mechanisms have been suggested to
account for the swollen vacuoles. Brown et al have proposed that
WTM blocks the transport of mannose 6-phosphate enzymes from
the TGN to the PLC, resulting in their missorting to the secretory
pathway (Brown et al, 1995); however, this hypothesis does not
account for the novel swollen vacuolar compartment. In contrast,
Reaves et al have proposed that wortmannin inhibits two
membrane traf®c events, speci®cally retrograde transport to the
TGN from the PLC and recycling from a novel late endosomal
compartment to lysosomes (Reaves et al, 1996). To determine
which of these hypotheses explained the presence of macrovesicles
in MeWo cells treated with WTM, the movement of newly
synthesized TRP-1 molecules within the post-Golgi region was
assessed by time-course experiments.
MeWo cells were treated with 1 mM WTM for variable times at
37°C (0, 15, 30, and 60 min), and then ®xed, stained for TRP-1,
and assessed by indirect immuno¯uorescent microscopy as
described. In the absence of WTM, TRP-1 positive vesicles
were typically seen as clustered in a juxtanucelar region and
scattered throughout the cytoplasm (Fig 3a). Within 15 min of
adding WTM, there was a redistribution of newly synthesized
TRP-1 positive vesicles to the periphery of the cell and within
dendrites (Fig 3b). The new vesicles appeared swollen and
arranged in a linear array forming a tubular network. With
prolonged WTM treatment (i.e., 1 h exposure) the tubular
network had disappeared, and all that remained were the
macrovesicles in a perinuclear distribution (Fig 3d).
The appearance of enlarged vesicles at the periphery and within
dendrites shortly after exposure to WTM, and the subsequent
formation of a tubular network and ultimately macrovesicles
centrally located within the cell after continued exposure to WTM,
Figure 3. WTM induces the formation of a
novel TRP-1 positive compartment in a
time-course fashion. MeWo cells were exposed
to WTM (1 mM) for various times at 37°C: (a)
untreated, (b) 15 min, (c) 30 min, and (d) 1 h.
Arrows indicate the formation tubular network of
TRP-1 enriched vesicles, and arrowheads point to
swollen TRP-1 vesicles.
Figure 2. WTM inhibits PI 3-kinase activity in vitro. MeWo cells
lysates were immuno-precipitated with antibody to its p110 subunit.
Proteins released from the washed protein A-sepharose beads were
assayed for PI 3-kinase activity in the presence of various concentrations
of WTM, [a±32P]ATP, and phosphatidylinositol as described in the
Materials and methods. The lipid products were extracted and separated by
TLC. Results are presented as percentage activity of that seen in
untreated control samples. (a) PI3-kinase activity in the presence of
WTM; (b) autoradiogram.
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may suggest the movement of TRP-1 from a peripheral vesicular
compartment to a more central compartment. Delivery into the
novel swollen TRP-1 vacuolar compartment seems to be unaffec-
ted; however, traf®cking downstream would appear to be blocked,
accounting for the progressive enlargement of the centrally located
vesicles with prolonged exposure to WTM. These conclusions are
consistent with the ®ndings of Reaves et al that WTM inhibits
membrane traf®cking events of lysosomal type I integral membrane
proteins between a novel cation-independent mannose-6-phos-
phate receptor (CI-M6PR)-negative late endosomal compartments
and lysosomes (Reaves et al, 1996). Our observations raise the
possibility that TRP-1 sorting in the presence of WTM occurs via
late endosomal/PLC compartments.
WTM-induced tubular network and macrovesicles are part
of the endosomal pathway To determine further whether
WTM-induced tubular network and macrovesicles were of
endosomal origin, we examined the accessibility of the novel
vesicular compartment to extracellularly added antibody to TRP-1.
The latter was chosen because it has been shown that TRP-1 is
associated with a vacuolar system accessible from the extracellular
space (Giacomini et al, 1992). Similarly, it has been shown that
antibodies to the luminal domain of an integral membrane protein
(e.g., TGN38) can become internalized and will follow the
endocytic route of that endogenous protein (Reaves et al, 1996).
Although melanocytes are capable of nonspeci®c endocytosis, we
reasoned that by speci®cally targeting TRP-1 we would be able to
determine the relationship of the novel vesicular compartment to
the endosomal system.
To discern the pathway of internalized anti-TRP-1 immuno-
globulin, time-course experiments were performed and the staining
pattern of anti-TRP-1 antibody was contrasted with endogenous
TRP-1 expression after WTM treatment. Speci®cally, MeWo cells
were incubated in the presence of WTM (1 mM) for 30 min,
followed by mouse MoAb to TRP-1 (i.e., HMSA-5) for 5, 15, or
30 min. Cells were ®xed in methanol/acetone and stained for
TRP-1 immunoglobulins using rhodamine-labeled goat antimouse
IgG. The slides were then washed free of antibodies, incubated
with primary rabbit polyclonal antibodies to TRP-1 (a-PEP-1),
followed by ¯uorescein-labeled swine antirabbit IgG (as an
indicator or endogenous TRP-1 expression).
Within 5 min of incubation internalized TRP-1 immuno-
globulins were distributed in enlarged, peripherally located vesicles
(Fig 4a), and by 30 min internalized immunoglobulins were
limited to more centrally located macrovesicles (Fig 4e). The
distribution was nearly identical to that observed with the
constitutive distribution of TRP-1 in WTM-treated MeWo cells
(Fig 4b, d, f). The accessibility of the novel vacuolar compartment
induced by WTM to extracellularly added immunoglobulin
supports the notion that it is of endosomal derivation. The near
perfect colocalization of internalized TRP-1 antibodies with
endogenous TRP-1 suggests plasma membrane expression of
TRP-1, and is consistent with the observations of Jimbow et al
and Xu et al that a small portion of cellular gp75 can be found on
the cell surface on melanoma cells (Jimbow et al, 1993; Xu et al,
1997).
WTM-induced swollen compartment is related to the late
endosomes/prelysosomes To determine the location of the
WTM-induced macrovesicular compartment within the
endosomal system, cells were stained for the late endosomal/PLC
markers CD63, LAMP-1, and CI-M6PR. The staining pattern of
the above antigens was contrasted with endogenous expression of
TRP-1 in the absence or presence of WTM.
In untreated MeWo cells, TRP-1 and CI-M6PR are found in a
juxtanuclear position with some colocalization (Fig 5a, c). On
exposure to WTM, CI-M6PR positive vesicles in MeWo cells
appeared swollen, as previously reported by Reaves et al (1996).
Although the centrally located TRP-1 macrovesicles partially
colocalized with the swollen CI-M6PR vesicles, there was minimal
Figure 4. The distribution of internalized
immunoglobulins to TRP-1 is similar to the
endogenous distribution TRP-1 in WTM-
treated MeWo cells, suggesting that the
WTM-induced vesicular compartment is part
of the endosomal pathway. MeWo cells were
incubated in the presence of 1 mM WTM for
30 min, followed by MoAb to TRP-1 (i.e.,
HMSA-5) for 5 min (a, b), 15 min (c, d), and
30 min (e, f). The distribution of internalized anti-
TRP-1 antibodies was assessed using secondary
rhodamine-labeled goat antimouse IgG (a, c, e).
The distribution of endogenous TRP-1 was
determined by incubating methanol/acetone ®xed
slides with primary antibody to TRP-1 (a-PEP1),
followed by ¯uorescein-labeled goat antimouse
IgG (b, d, f). Arrows indicate the tubular network
of TRP-1-enriched vesicles, and arrowheads point
to swollen TRP-1 vesicles.
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colocalization of CI-M6PR with the peripheral TRP-1 vesicles
(Fig 5b, d).
In contrast, LAMP-1 was found to partially colocalize with
TRP-1 in the absence of WTM (Fig 5e, g) as previously noted
(Zhou et al, 1993). In the presence of WTM there was considerable
colocalization of LAMP-1 and TRP-1, suggesting a convergence of
the respective vesicles at a common compartment such as the PLC
due to blocked downstream membrane traf®c (Fig 5f, h).
In the absence of WTM, CD63 and TRP-1 appear to largely
colocalize to a vesicular compartment in a juxtanuclear position
(Fig 5i, k). After WTM treatment there appears to be a divergence
of CD63 and TRP-1 vesicles. Although the staining pattern for
CD63 vesicles was markedly altered by WTM, the majority
retained their normal size, and only a minority were enlarged. Both
swollen and normal sized CD63 positive vesicles colocalized with
TRP-1 vesicles, but only partially (Fig 5j, l).
The colocalization of LAMP-1, as well as the partial colocaliza-
tion of CD63 and CI-M6PR with TRP-1 vesicles after exposure
to WTM, supports the notion that melanosomes are of endosomal/
lysosomal lineage, and would place the novel TRP-1 compartment
induced by WTM in the vicinity of the PLC.
WTM does not affect the intracellular traf®cking of
TRP-1 From the above observations it was clear that WTM
has a profound effect on the distribution and morphology of
vesicles containing newly synthesized TRP-1; however, it was less
apparent what effect WTM had on the intracellular traf®cking of
TRP-1. In contrast, with lysosomal enzymes it is known that
WTM can inhibit the normal processing and delivery of these
proteins (Brown et al, 1995). To examine the potential effects of
WTM on the intracellular traf®cking of TRP-1, MeWo cells were
pulse-labeled with [35S] methionine, chased for various times either
in the presence or absence of WTM and analyzed by SDS-PAGE.
WTM did not appear to affect maturation or the rate of processing
of TRP-1 (Fig 6a). This would suggest that WTM does not
interfere with the constitutive pathway for TRP-1 transport.
Figure 5. The WTM-induced swollen
compartment appears to be related to the
late endosomes/prelysosomes. MeWo cells
were untreated (a, c, e, g, i, k) or treated with
WTM (1 mM) (b, d, f, h, j, l) for 1 h at 37°C.
Methanol/acetone-®xed cells were double-labeled
with mouse MoAb to TRP-1 (a, b, e, f, i, j) (as
detected with a rhodamine-labeled goat antimouse
IgG), and with rabbit polyclonal antibodies to CI-
M6PR (c, d), LAMP-1 (g, h), or CD63 (k, l) (as
detected with ¯uorescein-labeled swine antirabbit
IgG). Arrows indicate sample sites of colocalization
of TRP-1 with the lysosomal markers, whereas
arrowheads demonstrate representive sites of
vesicular structures that do not colocalize.
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WTM-induced vesicular compartment is not blocked by
brefeldin A and is dependent on GTP-binding proteins
Brefeldin A (BFA) induces the formation of a fused network of
membranes within homotypic systems such as between the ER and
the cis and medial Golgi, and between TGN and early endosomes,
respectively (Lippincott-Schwartz et al, 1991). BFA also prevents
membrane traf®c between heterotypic systems (Lippincott-
Schwartz et al, 1991), but does not appear to interfere with a
unique population of carrier vesicles that migrate along
microtubules to late endosomes/PLC. It is thought that BFA
blocks vesicular traf®c by inhibition of nucleotide exchange onto
ADP-ribosylation factor (ARF), and thereby prevents the assembly
of cytosolic coat proteins. By comparing the effects of BFA on
MeWo cells with WTM, we hope to gain some insight as to the
origin of the WTM-induced vesicles, its relationship to the
endosomal system, and the requirement for GTP-binding proteins.
The effect of BFA on the sorting of TRP-1 in MeWo cells was
assessed by pulse-chase experiment and indirect immuno¯uores-
cence analysis. Cells were exposed to BFA alone (50 mg per ml) for
1 h (Fig 7b), or BFA for 1 h followed by WTM (1 mM) (Fig 7c)
for 1 h, or conversely WTM for 1 h followed by BFA treatment
(Fig 7d). In the presence of BFA, TRP-1 failed to undergo full
maturation. In fact, BFA resulted in a gradual reduction in the
molecular weight of TRP-1 from 72 to 69 kDa (typical for ER
distributed TRP-1 molecules), and was likely due to blocked
processing of the glycoprotein by Golgi-derived mannosidases
within the ER (Fig 6b). On immuno¯uorescence analysis, TRP-1
in the presence of BFA appeared to be limited to a diffuse ``smear''
located in a juxtanuclear position in which no distinct vesicles or
tubules were apparent (Fig 7b). The ``smear'' likely represents a
mixed ER/Golgi system as a normal retrograde pathway from the
Golgi to the ER is known to persist after BFA treatment. This
conclusion is also consistent with the pulse-chase experiment in
which we found the failure of full TRP-1 maturation in the
presence of BFA. Prior treatment of MeWo cells with BFA for 1 h
prevented the appearance of the WTM-induced compartment
(Fig 7c). In contrast to BFA alone, the combined treatment (BFA
followed by WTM) resulted in the appearance of faint TRP-1
positive vesicles within the juxtanuclear located ``smear'', and likely
represented a gradual return of antegrade membrane traf®c out
from the TGN after BFA treatment. When cells were pretreated
with WTM followed by BFA, the peripheral vacuolar compart-
ment induced by BFA was still evident; however, macrovesicles
were not apparent (Fig 7d). The resistance of the WTM-induced
peripheral vesicular compartment to BFA raises the possibility that
it represents carrier vesicles that exist between early and late
endosomes, and that TRP-1 sorting in the presence of WTM
occurs via the endosomal pathway.
Microtubule function is required for the formation of the
WTM-induced TRP±1 compartment and is dependent on
GTPase The formation of a tubulo-vesicular network by WTM,
and the resistance of that vacuolar compartment to BFA treatment,
Figure 7. Brefeldin A does not induce
tubulo-vesicular structures or macrovesicles,
and can either prevent or diminish the
effects of WTM on MeWo cells. MeWo cells
were (a) untreated, or exposed to (b) BFA alone
(50 mg per ml) for 1 h, (c) BFA for 1 h followed
by WTM (1 mM) for 1 h, or conversely (d)
WTM for 1 h followed by BFA. Slides were ®xed
in methanol/acetone, stained with antibody to
TRP-1 followed by ¯uorescein-labeled goat
antimouse IgG, and processed as per above.
Figure 6. WTM does not affect the processing of TRP-1. In
contrast, Brefeldin A (BFA) interferes with the glycosylation of TRP-1.
MeWo cells were pulse-labeled with [35S] methionine for 5 min, and
chased for various times either in the presence or absence of (a) WTM
(1 mM) or (b) BFA (50 mg per ml). As WTM is unstable at 37°C, it was
replenished every hour during the entire chase period. Cells were lyzed
in RIPA buffer for 30 min at 4°C and centrifuged at 12 000 3 g for
15 min. The postnuclear-supernatants were subjected to a preclearing
process in a mixture of mouse serum agarose and protein-A sepharose for
2 h at 4°C. The precleared extracts were immuno-precipitated with anti-
TRP-1 antibody and analyzed by SDS-PAGE and followed by
¯uorography.
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led us to speculate that the peripheral vesicles represent carrier
vesicles that are dependent on functioning microtubules. To
examine this possibility, MeWo cells were exposed to the
microtubule-disrupting agent nocodazole (20 mg per ml) for
10 min prior to adding WTM and then analyzed by immuno-
¯uorescence microscopy. We found that the formation of the
tubular network and macrovesicles associated with WTM
treatment was reduced by prior exposure to nocodazole (Fig 8b).
It has been suggested that the effects of WTM on endosomal/
lysosomal systems is mediated by GTP-binding proteins (GTPases).
Shpetner et al have recently shown that AF±4, an inhibitor of ARF-
GTP hydrolysis resulting in a persistent ARF-GTP active state, can
prevent the effect of WTM on endosomes (Shpetner et al, 1996).
To assess the role of GTPases in modulating WTM-induced
tubulation/macrovesicle formation of melanosomes, MeWo cells
were incubated with AF±4 (30 mM NaF + 50 mM AlCl3) for
10 min followed by WTM for 30 min. Pretreatment of MeWo
cells with AF±4 reduced somewhat the central macrovesicular
compartment, and greatly diminished the peripheral tubulo-
vesicular network (Fig 8c).
The results suggest that the sorting of newly synthesized TRP-1
in the presence of WTM is dependent on trimeric GTP-binding
proteins (as low molecular weight GTPases are not as affected as
AF±4) and that its transport likely occurs via the endosomal
pathway. Our ®ndings are consistent with Shpetner et al (1996) that
AF4 can block the effect of WTM primarily through inhibition of
endocytic transport (Shpetner et al, 1996). The inability of AF±4 to
completely abolish the effect of WTM is consistent with the notion
that there are a saturable or limited number of AF±4-sensitive GTP-
binding proteins in the endosomal pathway.
The role of vacuolar H+-ATPase in the traf®cking of
TRP-1 It has been shown that an active vacuolar proton pump
is required for the correct targeting of proteins to the early
endosomes, late endosomes, and lysosomes (Van Weert et al, 1995).
Although melanosomes are known to express a proton-transporting
ATPase (Bhatnagar et al, 1993), its role in the transport of
tyrosinase-related proteins has not been fully explored.
Determining the role of endosomal acidi®cation in protein
sorting has been greatly facilitated by the use of acidophilic
agents such as NH4Cl, chloroquine, proton ionophores (e.g.,
monensin), and speci®c inhibitors of the vacuolar H+-ATPase such
as Ba®lomycin A1. Unfortunately, studies with these compounds
have been somewhat inconsistent with their effects on protein
traf®cking and their site of action (van Weert et al, 1995).
Ba®lomycin A1 appears to interfere with the formation of a
vesicular intermediate between early and late endosomes, and to
block the transport out from either the TGN or the Golgi via
inhibition of Golgi H+-ATPase.
To determine the role of endosomal acidi®cation in the
traf®cking of TRP-1 and the formation of WTM-induced
tubulo-vesicular network and macrovesicles, MeWo cells were
treated with either ba®lomycin A1 or chloroquine. Speci®cally,
MeWo cells were pretreated with WTM (1 mM) for 30 min and
then incubated in the presence of ba®lomycin A1 (0.1 mM) or
chloroquine (50 mM) for 30 min. The effects of the sorting of
TRP-1 were assessed by immuno¯uoresence analysis. Ba®lomycin
A1 treatment of MeWo cells completely abolished the effect of
WTM. Rather than seeing a tubulo-vesicular network and
macrovesicles (Fig 9a), ba®lomycin A1 treatment resulted in the
appearance of poorly de®ned TRP-1 positive vesicles, tightly
clustered in a perinuclear region (Fig 9b). In contrast, chloroquine
was much less effective in abrogating the effects of WTM. Non-
speci®c alkalization of MeWo cells with chloroquine interfered
with the formation of the tubulo-vesicular network, but did not
block the formation of macrovesicles (Fig 9c). These results suggest
that the sorting and transport of TRP-1 to the novel TRP-1
compartment is dependent on vacuolar H+-ATPase rather than a
low vesicular pH.
Possible explanations for our observations regarding the ability of
ba®lomycin A1 to negate the effect of WTM include: blockage in
the transport of proteins out from the TGN/Golgi, or inhibition of
the endosomal carrier vesicles. To determine which of these two
hypotheses applied to our ®ndings, MeWo cells were pulse-labeled
with [35S] methionine for 4 h at either 37°C or 20°C in the
presence of WTM (1 mM), and then incubated with either
ba®lomycin A1 (0.1 mM) or chloroquine (50 mM). Cells were
lyzed and then analyzed by SDS-PAGE. In the presence of WTM
alone at 37°C, there was no difference in the processing of TRP-1
as previously noted (Fig 10, column a, compare with Fig 6a).
Similarly, with chloroquine at 37°C, a 72±75 kDa band was seen,
indicating that luminal acidi®cation is not required for proper
processing of TRP-1 (Fig 10, column c). In contrast, ba®lomycin
A1 treatment at 37°C resulted in the appearance of a 69 kDa band
suggestive of impaired transport out from the TGN (Fig 10, column
b). This is supported by incubating MeWo cells at 20°C, which is
known to prevent the movement of proteins out from the TGN;
under these conditions a similar 69 kDa band was seen. The results
indicate that an active proton pump and not simple luminal
acidi®cation is required for TRP-1 processing in the presence of
WTM, and that the ATPase primarily functions at the level of the
TGN/Golgi.
Figure 8. The WTM-induced TRP-1 compartment is dependent
on microtubules and GTPases. MeWo cells were (a) untreated, (b)
pretreated with nocodazole (20 mg per ml) for 10 min, or (c) pretreated
with AlF±4 (30 mM NaF + 50 mM AlCl3) for 10 min, followed by the
addition of WTM for 30 min. Slides were processed for immuno-
¯uorescent microscopy as noted above.
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DISCUSSION
WTM has proved to be a powerful probe for characterizing the
sorting and transport of proteins. It binds irreversibly with the p110
catalytic subunit of PI 3-kinase in virtually all preparations tested to
date, and results in the formation of a swollen vesicular compart-
ment. Although WTM appears to be a selective inhibitor of PI 3-
kinase, the site at which the enzyme is interfered with is the subject
of considerable controversy. The majority of studies would suggest
that WTM interferes with the membrane traf®c out of the
endosomal compartment and results in the swelling of a novel late
endosomal compartment (Reaves et al, 1996). PI 3-kinase is the
molecular and biochemical machinery responsible for directing and
controlling the molecular exchange between heterotypic endocytic
organelles. PI 3-kinase has been shown to stimulate endosome
fusion in vitro, it mediates membrane traf®c between a late
endosomal compartment and lysosomes (Reaves et al, 1996), and
directs vesicular traf®c to and from lysosomes (Brown et al, 1995).
The results of our experiments with WTM on the melanoma cell
line MeWo indicate that the drug is a useful tool for assessing the
traf®cking of melanosomal proteins that may shed light onto the
ontogeny of the melanosome. We found that WTM resulted in a
redistribution of newly synthesized TRP-1 in MeWo cells. Shortly
after incubation with WTM, TRP-1 was found to be located
within a tubulo-vesicular network located at the periphery of the
cell. With continued exposure, TRP-1 was primarily distributed
within a centrally located swollen vacuolar compartment (``macro-
vesicles''). The initial effect of WTM was relatively rapid and
irreversible, and occurred in a concentration-dependent manner.
Possible origins of the swollen vacuolar structures include selective
budding from late endosomes, lysosomes, or PLC, as a result of the
inhibition of outgoing membrane traf®c in response to WTM
treatment.
The appearance of enlarged vesicles at the periphery and within
dendrites shortly after exposure to WTM, the subsequent forma-
tion of a tubular network, and ultimately, macrovesicles centrally
located within the cell, suggests the movement of TRP-1 from a
peripheral vesicular compartment to a more central compartment.
Brown et al have shown that WTM can interfere with the transport
of lysosomal TGN to the PLC resulting in their miss-sorting to the
secretory pathway (Brown et al, 1995). If this were the case we
would have expected an altered degree of maturation and rate of
biosynthesis of TRP-1, which we did not see. Delivery into the
novel swollen TRP-1 vacuolar compartment was unaffected,
therefore traf®cking downstream would appear to be blocked,
accounting for the progressive enlargement of the centrally located
vesicles with prolonged exposure to WTM. These conclusions are
consistent with the ®ndings of Reaves et al that WTM inhibits
membrane traf®cking events out from the late endosome/PLC
(Reaves et al, 1996); however, the delivery from the peripheral
endosomal compartment is not blocked as the swollen vesicular
compartment was accessible to extracellularly added immuno-
globulin.
The endosomal/lysosomal cascade in the intracellular transport
of secretory proteins is also regulated by adapter proteins. AP-1
recruitment to the TGN is under the control of ras-like GTPase
(ARF). Its binding is inhibited by BFA, which blocks nucleotide
exchange on ARF. Interestingly, AP-2 binding to the plasma
membrane is not blocked by BFA. Our observation of the
resistance of the unique compartment induced by WTM to BFA
treatment may be indicative of a different adapter complex. A third
ubiquitously expressed adapter-like complex known as AP-3 has
recently been described to be involved in pigment granule
biogenesis (Odorizzi et al, 1998). One of the subunits of AP-3
termed d-adaptin shares considerable homology with the garnet
locus of Drosophila, and it has been suggested that garnet protein is
required for proper biogenesis of eye pigment granules in Drosophila
(Honing et al, 1998). AP-2 has been shown to be a speci®c target
for PI3-P, and that interaction with these lipids can regulate the
recognition of endocytic signals, thereby increasing the speci®city
Figure 9. The WTM-induced TRP-1 compartment appears to
require functioning vacuolar H+-ATPase. MeWo cells were
incubated with (a) WTM (1 mM) for 30 min, followed by (b) Baf A1
(0.1 mM), or (c) chloroquine (50 mM), both for 30 min. Slides were
processed for immuno-¯uorescent microscopy as previously noted.
Figure 10. TRP-1 processing in the presence of WTM requires an
active proton pump and not simple luminal acidi®cation. MeWo
cells were pulse-labeled with [35S] methionine for 4 h at either 20°C or
37°C in the presence of (a) WTM (1 mM), followed by (b) ba®lomycin
A1 (0.1 mM), or (c) chloroquine (50 mM). Cells were lyzed, immuno-
precipitated with anti-TRP-1 antibody, and analyzed by SDS-PAGE.
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of sorting. AP-3 localizes to the Golgi and endosomal membranes.
At the level of the TGN, AP-3 function is dependent on ARF-1. It
has been postulated that AP-3 mediates the sorting of proteins at
the TGN, which bypasses the endosomal target of AP-1 dependent
vesicles, resulting in their more direct transport to the end organelle
(Honing et al, 1998). AP-3 binds to tyrosinase, and is dependent on
the di-leucine targeting motif of the cytoplasmic C-terminus.
In summary, these observations appear to support our previous
reports that raise the possibility that TRP-1 sorting to melanosomes
(from stage I to stage II) occurs via late endosomal compartment
(Jimbow et al, 2000a,b). The convergence of LAMP-1 and TRP-1
vesicles with WTM treatment also supports the notion that stage I
melanosomes are of late endosomal/PLC lineage, and would place
the novel TRP-1 compartment induced by WTM in the vicinity of
the PLC. Previous immunogold electron microscopy studies
revealed that CD63 is an integral membrane glycoprotein of late
endosomes and lysosomes (Metzelaar et al, 1991). WTM does not
appear to affect the morphology of lysosomes and the TGN
(Shpetner et al, 1996). The normal appearing CD63 positive
vesicles therefore likely represent lysosomes, whereas the swollen
CD63 positive vesicles that colocalize with TRP-1 are most likely
of late endosomal origin. The partial colocalization of TRP-1 with
CD63 and CI-M6PR vesicles upon exposure to WTM, would
imply a divergence of lysosomal and melanosomal pathways at the
late endosome during the intracellular transport of TRP-1 from
TGN. Our view may also be consistent with the recent report of
Raposo et al who proposed, based primarily upon immunoelectron
microscopic observation, that premelanosomes (stage I melano-
somes) and melanosomes (stage II±IV) represent a distinct lineage of
organelles, separable from conventional endosomes and lysosomes
within pigmented cells (Raposo et al, 1996, 2001).
This study was supported by the grant-in-aid from the Ministry of Education.
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